United Kingdom

M3 Inc (2413.T)

2413.T on Tokyo Stock Exchange

25 Sep 2018
Change (% chg)

-- (--)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Latest Key Developments (Source: Significant Developments)

Shin Nippon Biomedical Laboratories to sell unit for 1 bln yen
Friday, 31 Aug 2018 

Aug 31(Reuters) - Shin Nippon Biomedical Laboratories Ltd <2395.T>:Says it plans to sell 100 percent voting power in unit Shin Nippon Biomedical Laboratories SMO, Ltd., for 1 billion yen, to M3 Inc <<<2413.T>>>.Transaction date on Oct. 1.  Full Article

M3 to buy 75.4 pct voting power in Y's for 1.53 bln yen
Thursday, 30 Aug 2018 

Aug 30(Reuters) - M3 Inc <2413.T>:Says it plans to acquire 75.4 percent voting power in Y's,Inc., which is mainly engaged in operation of cerebral infarction rehabilitation facility, for 1.53 billion yen .Transaction date on Aug. 31.Says it will increase voting power in Y's to 81.2 percent from 5.8 percent .  Full Article

M3 to fully buy AXIO Medical Holdings Limited for 102 mln euros
Friday, 7 Oct 2016 

M3 Inc <2413.T>:Says it plans to fully buy AXIO Medical Holdings Limited for 102 million euros(advisory fee included) at the end of December.  Full Article

Electra Partners sells Vidal Group to M3 Inc
Friday, 7 Oct 2016 

Electra Private Equity Plc : Electra partners is pleased to announce that its portfolio company axio group has received a binding offer from m3, inc, to purchase vidal group , a leading european provider of reference drug information for healthcare professionals, for eur 100 million . Sale of vidal would increase total cash proceeds received by electra from its investment in axio to almost £250 million, or 2.8x original cost, and total return, including electra's investment in remaining axio businesses, to 4.0x original cost .Based on today's exchange rates, electra private equity plc ("electra") would receive proceeds from axio of £55 million, an uplift of £17 million on valuation of electra's investment at 31 march 2016 and equivalent to an increase in its nav of 35 pence per share.  Full Article